cysteine and Ewing Sarcoma

cysteine has been researched along with Ewing Sarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ban, J; Jug, G; Kovar, H; Pospísilová, S; Siligan, C1
Bernstein, ML; Dubowy, RL; Fahey, RC; Newton, GL; Souid, AK1

Trials

1 trial(s) available for cysteine and Ewing Sarcoma

ArticleYear
WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:6

    Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Neoplasms; Child; Cyclophosphamide; Cysteine; Female; Humans; Ifosfamide; Infusions, Intravenous; Kinetics; Male; Mesna; Radiation-Protective Agents; Sarcoma, Ewing; Sulfhydryl Compounds; Time Factors

1999

Other Studies

1 other study(ies) available for cysteine and Ewing Sarcoma

ArticleYear
Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.
    Molecular cancer research : MCR, 2004, Volume: 2, Issue:5

    Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cysteine; DNA Damage; Humans; Intracellular Signaling Peptides and Proteins; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma, Ewing; Tumor Suppressor Protein p53

2004